Bandingkan Harga & Kinerja Multistrada Arah Sarana Tbk. (MASA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Multistrada Arah Sarana Tbk. dan Organon Pharma Indonesia Tbk.: Multistrada Arah Sarana Tbk. diperdagangkan di Rp6.200 (kapitalisasi pasar 56,93 T), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Multistrada Arah Sarana Tbk. jauh lebih besar — sekitar 545,3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MASA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 56,93 T | 104,4 M |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Multistrada Arah Sarana Tbk.
Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.
Selengkapnya di halaman MASA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
